Yunming Nie1,
Yanyue Wu2,
Xuefen Huang1,
Zhengzheng Chen1,
Yimin Zhou3
1Department of Anesthesia, Zhejiang Taizhou Hospital of Traditional Chinese Medicine, Taizhou, Zhejiang Province 318000;
2Department of Ophthalmology, Eye Hospital of Taizhou Municipal Hospital, Taizhou, Zhejiang Province 318000;
3Department of Anesthesiology, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, Zhejiang Province 325000, China.
For correspondence:- Yimin Zhou
Email: zhouyimin10826@163.com Tel:+8657756671319
Accepted: 17 February 2022
Published: 31 March 2022
Citation:
Nie Y, Wu Y, Huang X, Chen Z, Zhou Y.
C1q/tumor necrosis factor (TNF)-associated protein 6 (CTRP6) ameliorates the cognitive dysfunction induced by sevoflurane by activating AMPK/SIRT1 pathway in rats. Trop J Pharm Res 2022; 21(3):549-554
doi:
10.4314/tjpr.v21i3.14
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To evaluate the possible effects of C1q/tumor necrosis factor (TNF)-associated protein 6 (CTRP6) on postoperative cognitive dysfunction (POCD), including the potentially-related signaling pathway.
Methods: Behavioral analysis and cognitive impairment were assessed in each group. Immunoblots were used to determine the level of CTRP6 following sevoflurane-induced nerve injury. Hippocampal neurons were identified using Nissl staining, while inflammatory response following neuronal injury was monitored by enzyme-linked immunosorbent assay (ELISA) and quantitative polymerase chain reaction (qPCR). The involvement of adenosine monophosphate-activated protein kinase (AMPK)/sirtuin 1 (SIRT1) pathway was determined using immunoblot.
Results: CTRP6 alleviated sevoflurane-induced cognitive dysfunction in rats (p < 0.001). Moreover, CTRP6 reduced sevoflurane-induced nerve injury and inflammation in rats (p < 0.05).
Conclusion: CTRP6 ameliorates sevoflurane-induced cognitive dysfunction by activating AMPK/SIRT1 pathway, thus offering a novel target for POCD treatment.
Keywords: Postoperative cognitive dysfunction (POCD), C1q/Tumor necrosis factor (TNF) associated protein 6 (CTRP6), Nerve injury, Inflammation, AMPK/SIRT1 pathw